Alan Lennon

1.8k total citations
17 papers, 1.4k citations indexed

About

Alan Lennon is a scholar working on Molecular Biology, Ophthalmology and Genetics. According to data from OpenAlex, Alan Lennon has authored 17 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Ophthalmology and 4 papers in Genetics. Recurrent topics in Alan Lennon's work include Retinal Development and Disorders (12 papers), Retinal Diseases and Treatments (7 papers) and RNA regulation and disease (4 papers). Alan Lennon is often cited by papers focused on Retinal Development and Disorders (12 papers), Retinal Diseases and Treatments (7 papers) and RNA regulation and disease (4 papers). Alan Lennon collaborates with scholars based in United Kingdom, United States and Germany. Alan Lennon's co-authors include Alan F. Wright, Alan C. Bird, Thomas Meitinger, Alfredo Ciccodicola, B. Tulloch, R. Vervoort, Xinhua Shu, Alfons Meindl, Maria Giuseppina Miano and Richard A Axton and has published in prestigious journals such as Nature Genetics, PLoS ONE and Scientific Reports.

In The Last Decade

Alan Lennon

17 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Lennon United Kingdom 13 1.2k 550 369 250 156 17 1.4k
Nicole Weisschuh Germany 27 1.3k 1.1× 964 1.8× 377 1.0× 251 1.0× 124 0.8× 73 1.8k
Sarah Hull United Kingdom 22 812 0.7× 413 0.8× 292 0.8× 147 0.6× 127 0.8× 44 1.1k
Christina Chakarova United Kingdom 18 1.6k 1.4× 560 1.0× 287 0.8× 271 1.1× 330 2.1× 34 1.8k
Marijke N. Zonneveld Netherlands 15 1.5k 1.2× 679 1.2× 552 1.5× 270 1.1× 184 1.2× 16 1.6k
Wanda L. Hicks United States 17 781 0.7× 237 0.4× 358 1.0× 177 0.7× 164 1.1× 26 988
Kinga M. Bujakowska United States 19 1.1k 1.0× 507 0.9× 340 0.9× 143 0.6× 160 1.0× 46 1.3k
G. Jane Farrar Ireland 14 949 0.8× 297 0.5× 177 0.5× 189 0.8× 285 1.8× 29 1.1k
Fiona Blanco‐Kelly Spain 23 1.3k 1.1× 517 0.9× 358 1.0× 121 0.5× 132 0.8× 70 1.6k
Steffen Lenzner Germany 14 1.3k 1.1× 269 0.5× 674 1.8× 198 0.8× 107 0.7× 23 1.6k
C.F. Inglehearn United Kingdom 19 1.2k 1.0× 410 0.7× 167 0.5× 216 0.9× 363 2.3× 34 1.3k

Countries citing papers authored by Alan Lennon

Since Specialization
Citations

This map shows the geographic impact of Alan Lennon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Lennon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Lennon more than expected).

Fields of papers citing papers by Alan Lennon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Lennon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Lennon. The network helps show where Alan Lennon may publish in the future.

Co-authorship network of co-authors of Alan Lennon

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Lennon. A scholar is included among the top collaborators of Alan Lennon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Lennon. Alan Lennon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Stanton, Chloë M., Shyamanga Borooah, Camilla Drake, et al.. (2017). Novel pathogenic mutations in C1QTNF5 support a dominant negative disease mechanism in late-onset retinal degeneration. Scientific Reports. 7(1). 12147–12147. 27 indexed citations
2.
Oyón, Daniel, et al.. (2013). Investigating the Expression of Oncogenic and Tumor Suppressive MicroRNA in DLBCL.. PubMed. 39(1). 14–20. 6 indexed citations
3.
Hart, Jeffrey, Hai Wu, Albert P. Li, et al.. (2012). BK virus as a potential co-factor for HPV in the development of cervical neoplasia.. PubMed. 42(2). 130–4. 12 indexed citations
4.
Shu, Xinhua, Zhiqiang Zeng, Philippe Gautier, et al.. (2011). Knockdown of the Zebrafish Ortholog of the Retinitis Pigmentosa 2 ( RP2 ) Gene Results in Retinal Degeneration. Investigative Ophthalmology & Visual Science. 52(6). 2960–2960. 30 indexed citations
5.
Shu, Xinhua, Ulrich F. O. Luhmann, Tomás S. Alemán, et al.. (2011). Characterisation of a C1qtnf5 Ser163Arg Knock-In Mouse Model of Late-Onset Retinal Macular Degeneration. PLoS ONE. 6(11). e27433–e27433. 12 indexed citations
6.
Shu, Xinhua, Zhiqiang Zeng, Philippe Gautier, et al.. (2009). Zebrafish Rpgr is required for normal retinal development and plays a role in dynein-based retrograde transport processes. Human Molecular Genetics. 19(4). 657–670. 48 indexed citations
7.
Shu, Xinhua, B. Tulloch, Alan Lennon, et al.. (2007). Biochemical Characterisation of the C1QTNF5 Gene Associated with Late-Onset Retinal Degeneration. Advances in experimental medicine and biology. 572. 41–48. 10 indexed citations
8.
Shu, Xinhua, B. Tulloch, Alan Lennon, et al.. (2006). Disease mechanisms in late-onset retinal macular degeneration associated with mutation in C1QTNF5. Human Molecular Genetics. 15(10). 1680–1689. 45 indexed citations
9.
Shu, Xinhua, Andrew M. Fry, B. Tulloch, et al.. (2005). RPGR ORF15 isoform co-localizes with RPGRIP1 at centrioles and basal bodies and interacts with nucleophosmin. Human Molecular Genetics. 14(9). 1183–1197. 93 indexed citations
10.
Wright, Alan F., Sharon Schwartz, Tomás S. Alemán, et al.. (2004). Mutation analysis ofNR2E3 andNRL genes in Enhanced S Cone Syndrome. Human Mutation. 24(5). 439–439. 92 indexed citations
11.
Wang, Ying, et al.. (2004). Determination of secondary chromosomal aberrations of chronic myelocytic leukemia. Cancer Genetics and Cytogenetics. 153(1). 53–56. 10 indexed citations
12.
Hayward, Caroline, Xinhua Shu, Artur V. Cideciyan, et al.. (2003). Mutation in a short-chain collagen gene, CTRP5 , results in extracellular deposit formation in late-onset retinal degeneration: a genetic model for age-related macular degeneration. Human Molecular Genetics. 12(20). 2657–2667. 150 indexed citations
13.
Vervoort, R., Alan Lennon, Alan C. Bird, et al.. (2000). Mutational hot spot within a new RPGR exon in X-linked retinitis pigmentosa. Nature Genetics. 25(4). 462–466. 365 indexed citations
14.
Dry, Katherine L., Forbes Manson, Alan Lennon, et al.. (1999). Identification of a 5? splice site mutation in theRPGR gene in a family with X-linked retinitis pigmentosa (RP3). Human Mutation. 13(2). 141–145. 35 indexed citations
15.
Meindl, A, Katherine L. Dry, Karin A. Herrmann, et al.. (1996). A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X–linked retinitis pigmentosa (RP3). Nature Genetics. 13(1). 35–42. 391 indexed citations
16.
He, Lin, S. W. Morris, Alan Lennon, et al.. (1996). A genome-wide search for linkage in a large bipolar family. Psychiatric Genetics. 6(3). 123–130. 6 indexed citations
17.
Dry, Katherine L., Micheala A. Aldred, Forbes Manson, et al.. (1995). Identification of a novel gene, ETX1, from Xp21.1, a candidate gene for X-linked retinitis pigmentosa (RP3). Human Molecular Genetics. 4(12). 2347–2353. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026